Dr. Chu graduated from the Institute of Pharmacology, National Yang Ming Chiao Tung University. Her PhD studies mainly focused on the immune pathomechanism of drug hypersensitivity. She is a post-doc working in the Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Taiwan. The followings are her publications. 1. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol. 2021 Jun;141(6):1461-1472.e10. 2. Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nat Commun. 2019 Aug 8;10(1):3569. 3. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens. J Immunol Res. 2018 Dec 19;2018:4325874. 4. Rhein, An Anthraquinone Drug, Suppresses the NLRP3 Inflammasome and Macrophage Activation in Urate Crystal-Induced Gouty Inflammation. Am J Chin Med. 2019;47(1):135-151. 5. Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol. 2015 Sep;135(9):2237-2248.
Linkou Chang Gung Memorial Hospital
Taoyuan City, Taiwan